Related Experiment Video
Updated: Mar 8, 2026
Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
Published on: July 27, 2022
Late-breaking Trials from the 2016 American Heart Association's Scientific Sessions
Kyle D Buchanan1, M Chadi Alraies1, Alexandre H Kajita1
1Heart and Vascular Institute, MedStar Washington Hospital Center, 110 Irving St NW, Suite 4B-1, Washington, DC, 20010.
Insights
Late-breaking trials from the American Heart Association conference showcase advancements in heart failure devices and treatments for cardiovascular diseases like peripheral arterial disease and hypercholesterolemia, impacting clinical practice.
Area of Science:
- Cardiology
- Medical Devices
- Clinical Trials
Background:
- The American Heart Association (AHA) Scientific Sessions is a premier forum for presenting cutting-edge cardiovascular research.
- Late-breaking trials often represent significant shifts in clinical practice and patient care.
Abstract:
The late breaking trials released at the American Heart Association scientific sessions conference in November in New Orleans, LA covered a wide range of topics, including new devices within the field of heart failure, new registry data on transcatheter aortic valve replacement (TAVR) in intermediate risk patients, and medical management of peripheral arterial disease, coronary artery disease, and hypercholesterolemia. The following review highlights the late breaking trials presented at the conference that will have significant impact on clinical practice.
